APA (7th ed.) Citation

Hassan, R., Cohen, S. J., Phillips, M., Pastan, I., Sharon, E., Kelly, R. J., . . . Laheru, D. (2010). Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers. Clinical cancer research, 16(24), 6132-6138. https://doi.org/10.1158/1078-0432.CCR-10-2275

Chicago Style (17th ed.) Citation

Hassan, Raffit, Steven J. Cohen, Martin Phillips, Ira Pastan, Elad Sharon, Ronan J. Kelly, Charles Schweizer, Susan Weil, and Daniel Laheru. "Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers." Clinical Cancer Research 16, no. 24 (2010): 6132-6138. https://doi.org/10.1158/1078-0432.CCR-10-2275.

MLA (9th ed.) Citation

Hassan, Raffit, et al. "Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers." Clinical Cancer Research, vol. 16, no. 24, 2010, pp. 6132-6138, https://doi.org/10.1158/1078-0432.CCR-10-2275.